Pancreatitis may induce a spectrum of venous and arterial vascular complications. However, hepatic infarction complicated with acute pancreatitis seldom occurs because of the unique vascular configuration of the liver. We herein describe an extremely rare and unique case in which simultaneous portal vein and hepatic vein thrombosis were present. We precisely assessed both hepatic hemodynamics and hepatocellular function using sequential multidetector computed tomography and gadoxetate disodium-enhanced magnetic resonance imaging, which may provide useful information on the pathophysiological state and diagnosis of hepatic infarction.
Introduction
Pancreatitis may induce a spectrum of venous and arterial vascular complications (1) (2) (3) (4) . For instance, venous thrombosis is caused by stasis, spasm, and mass effects from the surrounding inflamed pancreas, as well as by direct damage of the venous wall by liberated enzymes (2, 5) . However, hepatic infarction complicated with acute pancreatitis seldom occurs because of the unique hepatic vascular configuration (6) . The liver possesses a dual arterial and portal blood supply and a venous drainage system (7); moreover, a rich network of intra-and extrahepatic accessory and collateral arteries in this organ create a complex compensatory system in the event of reduced or absent blood flow (8, 9) .
It is important to precisely evaluate any damage that may occur following hepatic infarction because the treatment and prognosis depend on the extent of the affected region (10, 11) . Conventional computed tomography (CT) is generally considered the most useful modality for diagnosing this condition despite few published large case series (10, 12, 13) . However, hepatic infarction is best evaluated from two perspectives: hepatic hemodynamics and hepatocellular function. The emergence of contrast-enhanced multidetector CT (MDCT) and dynamic magnetic resonance (MR) imaging has recently enabled more detailed hepatic hemodynamic assessments. In addition, the newly introduced gadoxetate disodium is a biphasic hepatobiliary MR contrast agent that permits the visualization of both extracellular fluid and hepatocyte function. Thus, hemodynamic characteristics can be evaluated by dynamic contrastenhanced MR imaging, while hepatocellular function is assessed by hepatobiliary phase imaging using the balance between hepatocelluar uptake of gadoxetate disodium and its excretion through the renal and biliary systems (14, 15) . We herein present a case of right hepatic infarction complicated with acute pancreatitis displaying simultaneous portal and hepatic vein thromboses. Furthermore, we examined the clinical course of the infarction hemodynamically and functionally using gadoxetate disodium-enhanced MR imaging in addition to MDCT, which may provide useful information on the pathophysiological state and diagnosis of hepatic infarction.
Case Report
A 70-year-old woman presented at our hospital complaining of sudden upper abdominal pain and cold night sweats. Her medical history was notable for hypertension and hyperlipidemia that was being treated with oral medication. She had a heart rate of 80 bpm, a blood pressure of 157/90 mm/ Hg, and a body temperature of 35.7 . A physical examination disclosed abdominal pain, liver tenderness, and back pain. Her blood tests were abnormal for inflammatory reaction, coagulation ability, liver function, biliary system, and pancreatic enzyme levels, but there was no evidence of thrombophilia (Table) . CT disclosed a swollen pancreatic head, high density areas in the gallbladder (Fig. 1) , wedgeshaped parenchymal hypoperfused areas in the right portal vein ( Fig. 2 ) and hepatic venous congestion (Fig. 3) during the arterial phase, and right hepatic vein thrombosis in the delayed phase (Fig. 4) . Accordingly, the patient was diagnosed to have acute pancreatitis and hepatic infarction caused by portal and hepatic vein thromboses. Intensive care with transfusions, protease inhibitor treatment, antibiotics, and anticoagulation therapy resulted in amelioration of the patient's clinical, laboratory, and CT imaging findings (Fig. 4) . On the 19th day after presentation, we performed gadoxetate disodium-enhanced MR imaging to precisely evaluate the extent of the hepatic infarction area. We identified a region with both a perfusion defect and hepatocyte dysfunction that was smaller than the perfusion reduction noted during her early disease onset (Fig. 5) . The patient was discharged on the 24th day with continued warfarin medication. She provided her informed written consent for these findings to be described in this case report.
Discussion
The present case is noteworthy for two main reasons. First, hepatic infarction complicated with acute pancreatitis is extremely rare. The patient's infarct pathogenesis might have been associated with portal and hepatic vein thromboses, which may shed light on the pathophysiological state of her hepatic infarction. Secondly, we could examine the hepatic infarction both hemodynamically and functionally using gadoxetate disodium-enhanced MR imaging in addition to MDCT. This technique may be of assistance in the diagnosis, treatment, and prognosis of hepatic infarction.
Acute pancreatitis as the cause of hepatic infarction
In our patient, we witnessed portal and hepatic vein thromboses in the hepatic infarction region concurrent with acute pancreatitis. Hepatic venous congestion is characterized by patchy regions with diminished enhancement in the arterial phase and late enhancement in the equilibrium phase (16) . However, it is difficult to evaluate hepatic vein branch thrombosis and sequential liver stasis with the temporal and spatial resolutions provided by normal routine examinations. Consequently, hepatic vein thromboses may not have been sufficiently evaluated as a cause of hepatic infarction. In this case, portal and hepatic vein thromboses were visualized in the same region as the hepatic infarction, which exhibited both a perfusion defect and hepatocyte dysfunction. We therefore suspected that these thrombi led to severe hepatic stasis and insufficient arterial compensation, which ultimately resulted in the infarction.
Generally, the major causes of hepatic infarction include abdominal surgery or transcatheter arterial embolization for hepatocellular carcinoma, so it is thought that this condition is primarily related to mechanical vascular occlusion due to surgery and/or medication. Severe infarction and blood coagulation disorders are also common postoperative complications (10) . As for other causes of hepatic infarction, antiphospholipid syndrome, arteriosclerosis, polyarteritis no- dosa, disseminated intravascular coagulation (DIC) secondary to sepsis, trauma, non-obstructive intestinal ischemia, hemolysis, elevated liver enzymes, and low platelet (HELLP) syndrome have all been reported, but the association is not clear in most reported cases (10) .
In this case, none of the above factors were thought to play a role in the occurrence of the patient's hepatic infarction. Rather, we considered acute pancreatitis to be the main reason for the infarction-causing thrombi. Hepatic infarction accompanied with acute pancreatitis is extremely rare. To the best of our knowledge there have so far been no reports regarding hepatic vein thrombosis complicated with acute pancreatitis (1-4) . This might be due to the fact that hepatic vein thrombosis itself is very rare or that older imaging diagnostic tests are not sensitive enough to identify this condition. Here, we suspect that acute pancreatitis caused portal vein thrombosis through a conventional mechanism, namely, stasis, spasm, and mass effects from the surrounding inflamed pancreas, as well as direct damage to the venous wall caused by liberated enzymes (2, 5) . With regard to the patient's hepatic vein thrombosis, direct assault of the venous wall might have extended upward from the portal vein to the hepatic vein via the vascular sinusoids. The portal vein thrombosis might have also led to secondary blood flow stasis in the hepatic vein. As a reason why hepatic vein thrombosis only occurred in the right hepatic lobe, we hypothesize that because acute pancreatitis inflammation was mainly present around the pancreatic head, it might have induced laminar flow in the vein. Although portal vein thrombosis affected both the right and left hepatic lobes, hepatic vein thrombosis was only present in the right lobe, and it may have induced severe hepatic stasis and insufficient arterial compensation.
The major etiologies of acute pancreatitis include alcohol abuse, biliary stones, and severe hyperlipidemia. In this case, the patient suffered her first attack of pancreatitis in her 70s. She had no history of alcohol abuse or severe hyperlipidemia, but some gallbladder stones were observed on imaging. Because she experienced sudden pain onset and immediate attenuation in her clinical course, we considered the major cause of her acute pancreatitis to be gallbladder stones that may have been spontaneously excreted.
Gadoxetate disodium-enhanced MR imaging was helpful for identifying the hepatic infarction region
Both the treatment and prognosis of hepatic infarction depend on the extent of the lesion; therefore, it is important to precisely assess the affected region as soon as possible. A previous study suggested that partial infarctions should be treated conservatively, whereas lobar infarctions require hepatectomy (10) .
In our evaluation of the patient's hepatic infarction region, we attempted to estimate hepatic hemodynamics and hepatocellular function using MDCT and gadoxetate disodiumenhanced MR imaging, respectively. Gadoxetate disodium is an MR contrast medium used during dynamic studies that distributes predominantly in the extracellular fluid space in early phases and in hepatocytes in the hepatobiliary phase. Clinicians can thus evaluate hepatocellular function by contrast enhancement in gadoxetate disodium-enhanced MR imaging in the hepatobiliary phase. Conventional CT has been typically employed for diagnosing hepatic infarction (10, 12, 13) . However, the area that contained both the hepatic perfusion defect and hepatocyte dysfunction (4.3 mL in gadoxetate disodium-enhanced MR imaging in the hepatobiliary phase), which represented the definitive infarction region in this case, was smaller than the perfusion reduction seen in the early period of disease onset (35.6 mL on contrast-enhanced CT in the early phase), suggesting that CT-based perfusion diagnosis alone may risk overestimating the infarction size and unnecessary treatment. The recent development of MDCT and dynamic MR imaging has enabled Figure 5 . Gadoxetate disodium-enhanced MR imaging on the 19th day shows a definitive hepatic infarction at the periphery of the liver that is hyperintense on T2-weighted imaging with fat suppression (A), diffusion weighted imaging (B), and an apparent diffusion coefficient map (C) suggesting vasogenic edema. The area is hypointense on pre-contrast T1-weighted imaging with fat suppression (D) and hypointense on gadoxetate disodium-enhanced T1-weighted imaging with fat suppression in the arterial phase (E) and hepatobiliary phase (F). Note that the definitive infarct area in gadoxetate disodium-enhanced MR imaging is similar to the edematous and hypoperfused area on a contrastenhanced CT scan on the 11th day (Fig. 4E and F) and smaller than that on the first (Fig. 4A and B) and fourth days (Fig. 4C and D) .
physicians to visualize hepatic perfusion in greater detail. Furthermore, gadoxetate disodium-enhanced MR imaging permits the simultaneous estimation of hepatic hemodynamics and hepatocellular function, which may assist in the diagnosis of hepatic infarction. On the other hand, diffusionweighted imaging may aid the diagnosis of hepatic infarction because it shows an edematous lesion due to hepatic infarction as a hyperintense area. Apparent diffusion coefficient (ADC) maps are also helpful for identifying cytotoxic edema in acute infarction and vasogenic edema in subacute infarction. In this case, the hypo-enhanced area in the hepatobiliary phase in gadoxetate disodium-enhanced MR images corresponded to the hyperintense areas in diffusion-weighted images and the ADC map, which represented vasogenic edema due to subacute hepatic infarction. If diffusionweighted imaging had only been performed during the acute phase of hepatic infarction, then the ischemic or dysfunctional tissue, but not the infarct area, would have been visualized. Based on our findings, we treated the patient conservatively with anticoagulants, and she was remained asymptomatic.
Limitations
This case study was retrospective in nature. For the diagnosis and evaluation of the patient's hepatic infarction, we initially employed CT, which has conventionally been considered the most useful modality. However, we observed that the hypoperfused area initially presumed as the infarct diminished over time. Afterwards, we performed gadoxetate disodium-enhanced MR imaging for additional information on this condition; its biphasic characteristics likely explain the discrepancy in the estimation time of the infarction between MDCT and gadoxetate disodium-enhanced MR imaging.
In conclusion, we presented an extremely rare and unique case of hepatic infarction complicated with acute pancreatitis. The estimation of both hepatic hemodynamics and hepatocellular function by sequential MDCT and gadoxetate disodium-enhanced MR imaging revealed a difference between the extent of perfusion reduction at disease onset and that at the time of definitive infarction estimation. This technique may therefore be useful in the diagnosis, treatment, and prognosis of hepatic infarction.
